| Biomarker ID | 1420 |
| PMID | 24747338 |
| Year | 2014 |
| Biomarker | Macrophage Colony Stimulating Factor (M-CSF) |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa: (> 2 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Benign Prostatic Hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | 46 patients with PCa and 42 controls with BPH were selected for analysis |
| Senstivity | 78.26% |
| Specificity | 83.33% |
| AUC | 0.926 |
| Accuracy | TP=36; TN=35; FP=7; FN=10 |
| Level Of Significance | p<0.0001 |
| Method Used | Antibody Microarrays |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |